Back
Guardian Canadian Focused Equity ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
60
GCFE.TO
Guardian Canadian Focused Equity ETF
Last Price:
26.67
Seasonality Move:
--
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
32.49
Seasonality Move:
18.8%
Buy
60
Guardian Canadian Focused Equity ETF (GCFE.TO)
is a Buy
Is Guardian Canadian Focused Equity ETF a Buy, Sell or Hold?
- The current Guardian Canadian Focused Equity ETF [GCFE.TO] share price is $26.67. The Score for GCFE.TO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- GCFE.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GCFE.TO Stock Price Chart
What is Guardian Canadian Focused Equity ETF's stock price today?
-
The Guardian Canadian Focused Equity ETF share price today is $26.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GCFE.TO is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
GCFE.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 99 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.2 - 26.5) | Buy |
Bollinger Bands (100): | (24.35 - 26.11) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 33.6 | Sell |
Chaikin Money Flow: | -1084788 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.37 - 40.01) | Sell |
Bollinger Bands (100): | (36.55 - 42.35) | Sell |
GCFE.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.51 | Buy |
20-day SMA: | 26.39 | Buy |
50-day SMA: | 25.99 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 26.55 | Buy |
20-day EMA: | 26.4 | Buy |
50-day EMA: | 25.97 | Buy |
200-day EMA: | 0.27 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.19 | Sell |
20-day SMA: | 38.04 | Sell |
50-day SMA: | 37.88 | Sell |
200-day SMA: | 50 | Sell |
8-day EMA: | 35.96 | Sell |
20-day EMA: | 37.21 | Sell |
50-day EMA: | 38.25 | Sell |
200-day EMA: | 45.7 | Sell |
Guardian Canadian Focused Equity ETF Earnings Growth & GCFE.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.
Guardian Canadian Focused Equity ETF Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |